February 2017: A class-action lawsuit was filed against Quincy Bioscience for allegedly falsely representing that Prevagen supplements improve memory and provide cognitive benefits, and that the benefits of Prevagen are clinically proven when such claims are not true and without adequate support to make them. (Vanderwerff et al v. Quincy Bioscience Holding Company, Inc. et al, Case No. 17-cv-784, D. NJ.).
For more information about TINA.org’s investigation and legal efforts regarding Prevagen, click here.
For more information about Prevagen and TINA.org’s coverage of the product, click here.